Company news
Maravai Lifesciences Holdings, Inc. (NASDAQ:MRVI) news
Every Maravai Lifesciences Holdings, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
July 22, 2026
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
July 20, 2026
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
June 16, 2026
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
June 3, 2026
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
May 18, 2026
Maravai LifeSciences Reports First Quarter 2026 Financial Results
May 7, 2026
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
April 20, 2026
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
February 9, 2026
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
November 10, 2025
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
November 6, 2025
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
October 22, 2025
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
August 11, 2025
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
July 28, 2025
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
June 9, 2025
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 3, 2025
Maravai LifeSciencesReleases 2024 Sustainability Report
May 21, 2025
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
May 21, 2025
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to t...
May 20, 2025
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-ba...
May 14, 2025
Maravai Lifesciences Reports First Quarter 2025 Financial Results
May 12, 2025
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
May 1, 2025
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
March 18, 2025
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
February 25, 2025
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
February 24, 2025
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
February 4, 2025
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
February 3, 2025
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
January 28, 2025
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
January 8, 2025
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
December 5, 2024
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
November 12, 2024
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
November 7, 2024
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
November 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
October 15, 2024
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
September 24, 2024
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
August 28, 2024
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
August 12, 2024
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
August 7, 2024
Maravai LifeSciences Appoints Trey Martin to Board of Directors
July 29, 2024
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
July 10, 2024
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
July 2, 2024
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
May 13, 2024
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
May 9, 2024
Maravai LifeSciences Reports First Quarter 2024 Financial Results
May 8, 2024
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
April 30, 2024
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
April 18, 2024
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
April 10, 2024
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
March 12, 2024
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
February 22, 2024